Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies a
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies a This story matters for Science & Discovery readers tracking student. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. StudentNewsletter curates and briefs the science & discovery stories that matter. Our editorial policy →